These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8373539)

  • 1. Physical barriers to drug delivery in tumors.
    Curti BD
    Crit Rev Oncol Hematol; 1993 Feb; 14(1):29-39. PubMed ID: 8373539
    [No Abstract]   [Full Text] [Related]  

  • 2. Delivery of novel therapeutic agents in tumors: physiological barriers and strategies.
    Jain RK
    J Natl Cancer Inst; 1989 Apr; 81(8):570-6. PubMed ID: 2649688
    [No Abstract]   [Full Text] [Related]  

  • 3. Transvascular drug delivery in solid tumors.
    Yuan F
    Semin Radiat Oncol; 1998 Jul; 8(3):164-75. PubMed ID: 9634493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors.
    Drummond DC; Meyer O; Hong K; Kirpotin DB; Papahadjopoulos D
    Pharmacol Rev; 1999 Dec; 51(4):691-743. PubMed ID: 10581328
    [No Abstract]   [Full Text] [Related]  

  • 5. Barriers to drug delivery in solid tumors.
    Jain RK
    Sci Am; 1994 Jul; 271(1):58-65. PubMed ID: 8066425
    [No Abstract]   [Full Text] [Related]  

  • 6. Fluid transport in vascularized tumours and metastasis.
    Sleeman BD; Nimmo HR
    IMA J Math Appl Med Biol; 1998 Mar; 15(1):53-63. PubMed ID: 9549906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of molecular and cellular medicine to solid tumors.
    Jain RK
    J Control Release; 1998 Apr; 53(1-3):49-67. PubMed ID: 9741913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies.
    Chauhan VP; Stylianopoulos T; Boucher Y; Jain RK
    Annu Rev Chem Biomol Eng; 2011; 2():281-98. PubMed ID: 22432620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Calcium antagonist as biological modulator in cancer chemotherapy].
    Tsuruo T
    Nihon Rinsho; 1989 Aug; 47(8):1851-6. PubMed ID: 2573744
    [No Abstract]   [Full Text] [Related]  

  • 10. [Overcoming the multiple drug resistance of tumors].
    Donenko FV; Sitdikova SM; Moroz LV
    Vopr Onkol; 1991; 37(11-12):1034-41. PubMed ID: 1688278
    [No Abstract]   [Full Text] [Related]  

  • 11. Conditions of drug delivery within solid tumors, and noninvasive methods for studies in humans.
    Port RE
    Int J Clin Pharmacol Ther; 1997 Feb; 35(2):78-9. PubMed ID: 9147714
    [No Abstract]   [Full Text] [Related]  

  • 12. Mass transport in tumors: characterization and applications to chemotherapy.
    Jain RK; Weissbrod JM; Wei J
    Adv Cancer Res; 1980; 33():251-310. PubMed ID: 7006335
    [No Abstract]   [Full Text] [Related]  

  • 13. Transvascular and interstitial transport in tumors.
    Jain RK
    Adv Exp Med Biol; 1988; 242():215-20. PubMed ID: 2469315
    [No Abstract]   [Full Text] [Related]  

  • 14. Vascular and interstitial barriers to delivery of therapeutic agents in tumors.
    Jain RK
    Cancer Metastasis Rev; 1990 Nov; 9(3):253-66. PubMed ID: 2292138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macromolecular drug carrier systems in cancer chemotherapy: macromolecular prodrugs.
    Takakura Y; Hashida M
    Crit Rev Oncol Hematol; 1995 Mar; 18(3):207-31. PubMed ID: 7695833
    [No Abstract]   [Full Text] [Related]  

  • 16. Tissue transport of anti-cancer drugs.
    Lankelma J
    Curr Pharm Des; 2002; 8(22):1987-93. PubMed ID: 12171524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and metabolism of Navelbine.
    Krikorian A; Rahmani R; Bromet M; Bore P; Cano JP
    Semin Oncol; 1989 Apr; 16(2 Suppl 4):21-5. PubMed ID: 2652317
    [No Abstract]   [Full Text] [Related]  

  • 18. Single cell model for simultaneous drug delivery and efflux.
    Yi C; Saidel GM; Gratzl M
    Ann Biomed Eng; 1999; 27(2):208-18. PubMed ID: 10199698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mathematical models of the steps involved in the systemic delivery of a chemotherapeutic to a solid tumor: From circulation to survival.
    Ulmschneider MB; Searson PC
    J Control Release; 2015 Aug; 212():78-84. PubMed ID: 26103439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uptake of low-density lipoprotein by malignant cells--possible therapeutic applications.
    Vitols S
    Cancer Cells; 1991 Dec; 3(12):488-95. PubMed ID: 1840290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.